Vault-13

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · CIK 1224962 · 13F filing filed 2024-08-16

SEC-registered investment adviser since 2010 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 25
Greenwich, CTUnited States United States1
Miami Beach, FLUnited States United States1
Sheridan, WYUnited States United States1
Water Mill, NYUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$4.1bn reported value -27.0% vs Q1 2024
107positions
47.3%in top 10
21 new 20 added 30 reduced 19 sold out vs Q1 2024

Options: 1 call positions ($5.3m notional), 2 put positions ($3.5m notional) – listed below, not included above.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 10,794,876 $441.4m10.65% 10.65% UnchangedShares held: Q3 2023 10.1m, Q4 2023 11.0m, Q1 2024 10.8m, Q2 2024 10.8m
2 AMICUS THERAPEUTICS INC COM FOLD FOLD 28,057,456 $278.3m6.72% 6.72% UnchangedShares held: Q3 2023 27.7m, Q4 2023 28.1m, Q1 2024 28.1m, Q2 2024 28.1m
3 ARCELLX INC COMMON STOCK ACLX ACLX 3,889,739 $214.7m5.18% 5.18% ReducedShares held: Q3 2023 4.0m, Q4 2023 4.5m, Q1 2024 3.9m, Q2 2024 3.9m -43.8k -43,817 -1.1%
4 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 25,933,142 $208.0m5.02% 5.02% AddedShares held: Q3 2023 12.0m, Q4 2023 12.0m, Q1 2024 19.3m, Q2 2024 25.9m +6.7m +6,660,151 34.6%
5 NUVALENT INC COM COM 2,549,077 $193.4m4.67% 4.67% ReducedShares held: Q3 2023 2.5m, Q4 2023 2.9m, Q1 2024 2.8m, Q2 2024 2.5m -234.4k -234,377 -8.4%
6 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 3,446,579 $141.5m3.42% 3.42% AddedShares held: Q3 2023 380.8k, Q4 2023 2.2m, Q1 2024 3.3m, Q2 2024 3.4m +178.0k +178,000 5.5%
7 VAXCYTE INC COM PCVX PCVX 1,862,608 $140.6m3.39% 3.39% ReducedShares held: Q3 2023 1.3m, Q4 2023 1.1m, Q1 2024 1.9m, Q2 2024 1.9m -70.2k -70,151 -3.6%
8 SOLENO THERAPEUTICS INC COM SLNO SLNO 3,204,976 $130.8m3.16% 3.16% AddedShares held: Q3 2023 3.1m, Q4 2023 3.1m, Q1 2024 3.1m, Q2 2024 3.2m +130.4k +130,434 4.2%
9 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 1,716,407 $117.6m2.84% 2.84% AddedShares held: Q3 2023 0, Q4 2023 108.0k, Q1 2024 1.1m, Q2 2024 1.7m +661.1k +661,052 62.6%
10 IMMATICS N.V SHS IMTX IMTX 8,086,159 $94.0m2.27% 2.27% AddedShares held: Q3 2023 3.5m, Q4 2023 3.5m, Q1 2024 4.6m, Q2 2024 8.1m +3.5m +3,503,750 76.5%
11 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 649,909 $89.5m2.16% 2.16% ReducedShares held: Q3 2023 159.2k, Q4 2023 270.8k, Q1 2024 804.4k, Q2 2024 649.9k -154.5k -154,500 -19.2%
12 APOGEE THERAPEUTICS INC COM COM 2,105,636 $82.9m2.00% 2.00% AddedShares held: Q3 2023 1.8m, Q4 2023 1.8m, Q1 2024 2.1m, Q2 2024 2.1m +45.2k +45,241 2.2%
13 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 264,600 $74.1m1.79% 1.79% ReducedShares held: Q3 2023 124.6k, Q4 2023 151.2k, Q1 2024 430.0k, Q2 2024 264.6k -165.4k -165,353 -38.5%
14 ARTIVION INC COM AORT AORT 2,793,703 $71.7m1.73% 1.73% AddedShares held: Q3 2023 931.4k, Q4 2023 931.4k, Q1 2024 2.7m, Q2 2024 2.8m +124.7k +124,725 4.7%
15 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 3,031,018 $71.3m1.72% 1.72% AddedShares held: Q3 2023 81.1k, Q4 2023 2.6m, Q1 2024 2.6m, Q2 2024 3.0m +474.3k +474,339 18.6%
16 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,476,203 $66.1m1.60% 1.60% UnchangedShares held: Q3 2023 1.3m, Q4 2023 1.3m, Q1 2024 1.5m, Q2 2024 1.5m
17 EVOLUS INC COM EOLS EOLS 5,753,798 $62.4m1.51% 1.51% UnchangedShares held: Q3 2023 1.5m, Q4 2023 4.0m, Q1 2024 5.8m, Q2 2024 5.8m
18 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 1,652,962 $62.3m1.50% 1.50% ReducedShares held: Q3 2023 1.5m, Q4 2023 2.0m, Q1 2024 2.3m, Q2 2024 1.7m -609.5k -609,500 -26.9%
19 CARGO THERAPEUTICS INC COM COM 3,683,004 $60.5m1.46% 1.46% AddedShares held: Q3 2023 0, Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.7m +235.0k +235,000 6.8%
20 ASTRIA THERAPEUTICS INC COM CATB CATB 6,485,420 $59.0m1.42% 1.42% UnchangedShares held: Q3 2023 2.2m, Q4 2023 4.0m, Q1 2024 6.5m, Q2 2024 6.5m
21 NATERA INC COM NTRA NTRA 530,000 $57.4m1.39% 1.39% ReducedShares held: Q3 2023 218.2k, Q4 2023 850.2k, Q1 2024 757.2k, Q2 2024 530.0k -227.2k -227,225 -30.0%
22 VERRICA PHARMACEUTICALS INC COM COM 7,099,182 $51.8m1.25% 1.25% UnchangedShares held: Q3 2023 5.0m, Q4 2023 7.1m, Q1 2024 7.1m, Q2 2024 7.1m
23 BIOHAVEN LTD COM BHVN BHVN 1,485,232 $51.6m1.24% 1.24% ReducedShares held: Q3 2023 751.8k, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 1.5m -239.8k -239,815 -13.9%
24 IMMUNOVANT INC COM IMVT IMVT 1,923,786 $50.8m1.23% 1.23% ReducedShares held: Q3 2023 3.8m, Q4 2023 2.3m, Q1 2024 3.0m, Q2 2024 1.9m -1.0m -1,039,426 -35.1%
25 MEIRAGTX HLDGS PLC COM MGTX MGTX 11,331,103 $47.7m1.15% 1.15% UnchangedShares held: Q3 2023 11.3m, Q4 2023 11.3m, Q1 2024 11.3m, Q2 2024 11.3m
26 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 1,268,735 $44.0m1.06% 1.06% AddedShares held: Q3 2023 1.1m, Q4 2023 383.3k, Q1 2024 994.3k, Q2 2024 1.3m +274.4k +274,412 27.6%
27 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 6,906,646 $39.2m0.95% 0.95% UnchangedShares held: Q3 2023 3.5m, Q4 2023 3.5m, Q1 2024 6.9m, Q2 2024 6.9m
28 CELCUITY INC COM CELC CELC 2,362,279 $38.7m0.93% 0.93% UnchangedShares held: Q3 2023 0, Q4 2023 1.5m, Q1 2024 2.4m, Q2 2024 2.4m
29 MEDTRONIC PLC SHS MDT MDT 490,665 $38.6m0.93% 0.93% ReducedShares held: Q3 2023 587.0k, Q4 2023 976.7k, Q1 2024 1.4m, Q2 2024 490.7k -938.9k -938,898 -65.7%
30 VIKING THERAPEUTICS INC COM VKTX VKTX 721,377 $38.2m0.92% 0.92% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 994.1k, Q2 2024 721.4k -272.7k -272,721 -27.4%
31 APPLIED THERAPEUTICS INC COM APLT APLT 8,005,000 $37.4m0.90% 0.90% UnchangedShares held: Q3 2023 0, Q4 2023 4.1m, Q1 2024 8.0m, Q2 2024 8.0m
32 AXSOME THERAPEUTICS INC COM AXSM AXSM 459,111 $37.0m0.89% 0.89% ReducedShares held: Q3 2023 481.6k, Q4 2023 1.0m, Q1 2024 1.1m, Q2 2024 459.1k -646.2k -646,230 -58.5%
33 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 3,933,307 $35.5m0.86% 0.86% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.1m, Q2 2024 3.9m +850.0k +850,000 27.6%
34 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,296,416 $35.2m0.85% 0.85% UnchangedShares held: Q3 2023 1.3m, Q4 2023 1.3m, Q1 2024 1.3m, Q2 2024 1.3m
35 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 2,433,725 $35.2m0.85% 0.85% ReducedShares held: Q3 2023 4.0m, Q4 2023 3.9m, Q1 2024 3.8m, Q2 2024 2.4m -1.3m -1,327,851 -35.3%
36 AKERO THERAPEUTICS INC COM AKRO AKRO 1,499,897 $35.2m0.85% 0.85% AddedShares held: Q3 2023 1.6m, Q4 2023 967.8k, Q1 2024 1.4m, Q2 2024 1.5m +112.4k +112,426 8.1%
37 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,856,417 $33.4m0.81% 0.81% ReducedShares held: Q3 2023 0, Q4 2023 555.6k, Q1 2024 2.3m, Q2 2024 1.9m -463.2k -463,229 -20.0%
38 ACRIVON THERAPEUTICS INC COMMON STOCK ACRV ACRV 5,360,858 $31.1m0.75% 0.75% AddedShares held: Q3 2023 3.0m, Q4 2023 3.0m, Q1 2024 3.0m, Q2 2024 5.4m +2.4m +2,353,000 78.2%
39 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 750,230 $31.0m0.75% 0.75% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 821.6k, Q2 2024 750.2k -71.4k -71,359 -8.7%
40 ADMA BIOLOGICS INC COM ADMA ADMA 2,771,000 $31.0m0.75% 0.75% ReducedShares held: Q3 2023 7.0m, Q4 2023 6.4m, Q1 2024 6.4m, Q2 2024 2.8m -3.7m -3,662,369 -56.9%
41 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,215,346 $30.8m0.74% 0.74% ReducedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.4m, Q2 2024 1.2m -196.7k -196,687 -13.9%
42 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 9,275,851 $30.7m0.74% 0.74% AddedShares held: Q3 2023 11.4m, Q4 2023 8.6m, Q1 2024 8.6m, Q2 2024 9.3m +682.3k +682,265 7.9%
43 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 12,594,211 $29.5m0.71% 0.71% UnchangedShares held: Q3 2023 9.1m, Q4 2023 12.6m, Q1 2024 12.6m, Q2 2024 12.6m
44 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 1,566,668 $27.6m0.67% 0.67% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.6m
45 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 61,800 $27.5m0.66% 0.66% ReducedShares held: Q3 2023 0, Q4 2023 55.0k, Q1 2024 101.8k, Q2 2024 61.8k -40.0k -40,000 -39.3%
46 ARVINAS INC COM ARVN ARVN 1,027,749 $27.4m0.66% 0.66% ReducedShares held: Q3 2023 0, Q4 2023 354.1k, Q1 2024 1.2m, Q2 2024 1.0m -208.9k -208,854 -16.9%
47 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,246,597 $26.8m0.65% 0.65% ReducedShares held: Q3 2023 1.5m, Q4 2023 1.7m, Q1 2024 1.8m, Q2 2024 1.2m -554.5k -554,471 -30.8%
48 DISC MEDICINE INC COM IRON IRON 553,437 $24.9m0.60% 0.60% ReducedShares held: Q3 2023 895.6k, Q4 2023 1.0m, Q1 2024 939.9k, Q2 2024 553.4k -386.4k -386,429 -41.1%
49 LIVANOVA PLC SHS LIVN LIVN 444,000 $24.3m0.59% 0.59% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 299.0k, Q2 2024 444.0k +145.0k +145,000 48.5%
50 CG ONCOLOGY INC COM CGON CGON 733,695 $23.2m0.56% 0.56% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.3m, Q2 2024 733.7k -570.4k -570,410 -43.7%
51 XENON PHARMACEUTICALS INC COM XENE XENE 583,256 $22.7m0.55% 0.55% ReducedShares held: Q3 2023 617.5k, Q4 2023 1.1m, Q1 2024 892.2k, Q2 2024 583.3k -309.0k -308,952 -34.6%
52 OCULAR THERAPEUTIX INC COM OCUL OCUL 3,324,468 $22.7m0.55% 0.55% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.3m, Q2 2024 3.3m
53 PEPGEN INC COM PEPG PEPG 1,410,438 $22.5m0.54% 0.54% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.4m, Q2 2024 1.4m
54 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,631,828 $21.2m0.51% 0.51% ReducedShares held: Q3 2023 1.0m, Q4 2023 1.7m, Q1 2024 3.7m, Q2 2024 1.6m -2.0m -2,025,271 -55.4%
55 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 2,545,881 $20.7m0.50% 0.50% UnchangedShares held: Q3 2023 2.4m, Q4 2023 2.4m, Q1 2024 2.5m, Q2 2024 2.5m
56 MERUS N V COM MRUS MRUS 300,000 $17.8m0.43% 0.43% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 300.0k
57 RAPPORT THERAPEUTICS INC COM RAPP RAPP 748,183 $17.4m0.42% 0.42% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 748.2k
58 TYRA BIOSCIENCES INC COM TYRA TYRA 1,007,367 $16.1m0.39% 0.39% AddedShares held: Q3 2023 360.0k, Q4 2023 360.0k, Q1 2024 669.2k, Q2 2024 1.0m +338.2k +338,208 50.5%
59 INHIBRX BIOSCIENCES INC COM INBX INBX 1,064,026 $15.1m0.36% 0.36% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.1m
60 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 1,558,500 $14.5m0.35% 0.35% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 750.0k, Q2 2024 1.6m +808.5k +808,500 107.8%
61 ATHIRA PHARMA INC COM COM 5,402,964 $14.3m0.35% 0.35% UnchangedShares held: Q3 2023 4.8m, Q4 2023 5.4m, Q1 2024 5.4m, Q2 2024 5.4m
62 ZYMEWORKS INC COM ZYME ZYME 1,667,711 $14.2m0.34% 0.34% AddedShares held: Q3 2023 1.4m, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.7m +592.9k +592,904 55.2%
63 CULLINAN THERAPEUTICS INC COM CGEM CGEM 749,916 $13.1m0.32% 0.32% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 749.9k
64 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 210,659 $12.9m0.31% 0.31% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 210.7k, Q2 2024 210.7k
65 INSMED INC COM PAR $.01 INSM INSM 180,000 $12.1m0.29% 0.29% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 180.0k
66 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 572,000 $11.6m0.28% 0.28% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 572.0k
67 ICON PLC SHS ICLR ICLR 31,250 $9.8m0.24% 0.24% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 31.2k
68 TEMPUS AI INC CL A TEM TEM 275,000 $9.6m0.23% 0.23% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 275.0k
69 ARRIVENT BIOPHARMA INC COM AVBP AVBP 415,000 $7.7m0.19% 0.19% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 415.0k, Q2 2024 415.0k
70 ENGENE HOLDINGS INC COM COM 800,000 $7.5m0.18% 0.18% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 998.9k, Q2 2024 800.0k -198.9k -198,888 -19.9%
71 ARS PHARMACEUTICALS INC COM SPRY SPRY 867,319 $7.4m0.18% 0.18% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 867.3k, Q2 2024 867.3k
72 ARGENX SE SPONSORED ADR ARGX ARGX 15,600 $6.7m0.16% 0.16% NewShares held: Q3 2023 150.6k, Q4 2023 0, Q1 2024 0, Q2 2024 15.6k
73 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 2,725,000 $6.3m0.15% 0.15% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.7m
74 VERU INC COM COM 7,063,277 $5.9m0.14% 0.14% AddedShares held: Q3 2023 1.1m, Q4 2023 5.6m, Q1 2024 5.6m, Q2 2024 7.1m +1.5m +1,478,578 26.5%
75 KALVISTA PHARMACEUTICALS INC COM KALV KALV 500,000 $5.9m0.14% 0.14% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 500.0k, Q2 2024 500.0k
76 RECURSION PHARMACEUTICALS IN CL A RXRX RXRX 769,230 $5.8m0.14% 0.14% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 769.2k
77 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 640,274 $5.6m0.13% 0.13% AddedShares held: Q3 2023 0, Q4 2023 589.6k, Q1 2024 589.6k, Q2 2024 640.3k +50.6k +50,628 8.6%
78 HELIX ACQUISITION CORP II CL A ORD SHS BBOT BBOT 500,000 $5.1m0.12% 0.12% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 500.0k, Q2 2024 500.0k
79 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 1,253,250 $4.5m0.11% 0.11% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.3m
80 CABALETTA BIO INC COM CABA CABA 585,045 $4.4m0.11% 0.11% ReducedShares held: Q3 2023 1.1m, Q4 2023 2.0m, Q1 2024 1.7m, Q2 2024 585.0k -1.1m -1,131,615 -65.9%
81 PRECISION BIOSCIENCES INC COM NEW DTIL DTIL 426,293 $4.1m0.10% 0.10% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 480.5k, Q2 2024 426.3k -54.2k -54,190 -11.3%
82 SKYE BIOSCIENCE INC COM NEW COM NEW 500,000 $4.0m0.10% 0.10% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 500.0k
83 TRINITY BIOTECH PLC SPONS ADR NEW SPONS ADR NEW 1,800,000 $3.8m0.09% 0.09% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.8m, Q2 2024 1.8m
84 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 35,205 $3.8m0.09% 0.09% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 245.2k, Q2 2024 35.2k -210.0k -210,000 -85.6%
85 LYRA THERAPEUTICS INC COM LYRA LYRA 12,757,562 $3.5m0.09% 0.09% UnchangedShares held: Q3 2023 12.8m, Q4 2023 12.8m, Q1 2024 12.8m, Q2 2024 12.8m
86 BIODESIX INC COM COM 2,173,880 $3.3m0.08% 0.08% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.2m
87 ENVVENO MEDICAL CORPORATION COM COM 623,315 $3.3m0.08% 0.08% UnchangedShares held: Q3 2023 781.6k, Q4 2023 623.3k, Q1 2024 623.3k, Q2 2024 623.3k
88 FOGHORN THERAPEUTICS INC COM FHTX FHTX 544,000 $3.1m0.08% 0.08% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 544.0k
89 NANOBIOTIX SPONSORED ADS NBTX NBTX 555,066 $2.8m0.07% 0.07% UnchangedShares held: Q3 2023 555.1k, Q4 2023 555.1k, Q1 2024 555.1k, Q2 2024 555.1k
90 ABSCI CORPORATION COM ABSI ABSI 700,000 $2.2m0.05% 0.05% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 700.0k, Q2 2024 700.0k
91 SPDR SER TR S&P BIOTECH XBI XBI 22,665 $2.1m0.05% 0.05% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 22.7k
92 X4 PHARMACEUTICALS INC COM COM 3,545,454 $2.1m0.05% 0.05% UnchangedShares held: Q3 2023 3.5m, Q4 2023 3.5m, Q1 2024 3.5m, Q2 2024 3.5m
93 FORTE BIOSCIENCES INC COM COM 3,265,359 $1.8m0.04% 0.04% UnchangedShares held: Q3 2023 3.3m, Q4 2023 3.3m, Q1 2024 3.3m, Q2 2024 3.3m
94 REVANCE THERAPEUTICS INC COM RVNC RVNC 600,000 $1.5m0.04% 0.04% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 600.0k, Q2 2024 600.0k
95 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 34,852 $1.4m0.03% 0.03% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 34.9k
96 FATE THERAPEUTICS INC COM FATE FATE 345,575 $1.1m0.03% 0.03% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 345.6k
97 KYVERNA THERAPEUTICS INC COM KYTX KYTX 150,000 $1.1m0.03% 0.03% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 150.0k, Q2 2024 150.0k
98 EAGLE PHARMACEUTICALS INC COM EGRX EGRX 173,365 $970.8k0.02% 0.02% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 173.4k
99 VBI VACCINES INC CDA COM NEW VAC VAC 1,261,710 $832.7k0.02% 0.02% UnchangedShares held: Q3 2023 1.4m, Q4 2023 1.4m, Q1 2024 1.3m, Q2 2024 1.3m
100 TACTILE SYS TECHNOLOGY INC COM TCMD TCMD 62,639 $747.9k0.02% 0.02% ReducedShares held: Q3 2023 707.2k, Q4 2023 707.2k, Q1 2024 903.1k, Q2 2024 62.6k -840.4k -840,446 -93.1%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
INHIBRX INC INBX INBX 4,256,104 $148.8m4.3m shares
FUSION PHARMACEUTICALS INC 6,825,395 $145.5m6.8m shares
SAREPTA THERAPEUTICS INC SRPT SRPT 525,683 $68.1m525.7k shares
LANDOS BIOPHARMA INC 1,486,991 $31.9m1.5m shares
TREACE MED CONCEPTS INC TMCI TMCI 2,304,954 $30.1m2.3m shares
AUTOLUS THERAPEUTICS PLC AUTL AUTL 4,330,745 $27.6m4.3m shares
REVOLUTION MEDICINES INC RVMD RVMD 618,885 $19.9m618.9k shares
ABBVIE INC ABBV ABBV 106,500 $19.4m106.5k shares
MOONLAKE IMMUNOTHERAPEUTICS MLTX MLTX 339,012 $17.0m339.0k shares
RAPT THERAPEUTICS INC 1,223,472 $11.0m1.2m shares
MORPHIC HLDG INC MORF MORF 288,221 $10.1m288.2k shares
COGENT BIOSCIENCES INC COGT COGT 883,333 $5.9m883.3k shares
IMMUNITYBIO INC IBRX IBRX 1,052,887 $5.7m1.1m shares
MACROGENICS INC MGNX MGNX 378,327 $5.6m378.3k shares
ESTABLISHMENT LABS HLDGS INC ESTA ESTA 82,299 $4.2m82.3k shares
NEWAMSTERDAM PHARMA COMPANY NAMS NAMS 175,000 $4.1m175.0k shares
SINGULAR GENOMICS SYSTEMS IN 2,126,893 $1.1m2.1m shares
KURA ONCOLOGY INC KURA KURA 48,200 $1.0m48.2k shares
AMYLYX PHARMACEUTICALS INC AMLX AMLX 300,000 $852.0k300.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
IMMUNOVANT INC IMVT · Call IMVTCall 200,000 $5.3m200.0k shares Added
CASSAVA SCIENCES INC FLNA · Put FLNAPut 183,000 $2.3m183.0k shares New
NOVAVAX INC NVAX · Put NVAXPut 100,000 $1.3m100.0k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.

CompanyTickerStakeChange ScheduleLast filed
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 ADGM 55.4%≈ $8.8m -2.1 pts 13G 2026-05-15
LEONABIO INC LONA · 13D · filed 2026-10-26 LONA 20.0%≈ $17.4m no change 13D 2026-10-26
LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 LYRA 15.6% 13D 2025-08-14
MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 MGTX 12.6%≈ $158.6m -0.3 pts 13D 2026-04-24
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 SLDB 11.2%≈ $120.3m -1.7 pts 13D 2026-08-14
PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 FRNM 10.1% new 13G 2026-07-23
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 10.0%≈ $141.1m no change 13G 2026-08-14
ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 ANRO 10.0%≈ $110.2m no change 13G 2026-08-14
OPUS GENETICS INC IRD · 13G · filed 2026-08-14 IRD 10.0%≈ $37.6m no change 13G 2026-08-14
ENGENE HOLDINGS INC 13G · filed 2026-08-14 10.0% no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 KPRX 10.0%≈ $1.2m new 13G 2026-08-10
ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 10.0% 13G 2026-02-17
ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 OBIO 10.0%≈ $24.5m 13G 2025-11-14
TRINITY BIOTECH PLC 13D · filed 2026-05-04 9.9% no change 13D 2026-05-04
OUTSET MED INC OM · 13G · filed 2025-02-28 OM 9.5% new 13G 2025-02-28
NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 NAUT 9.1%≈ $21.8m -1.0 pts 13D 2026-08-14
KARDIGAN INC KARD · 13D · filed 2026-10-01 KARD 8.8%≈ $196.9m -0.1 pts 13D 2026-10-01
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 IRLA 8.4%≈ $1.7m new 13G 2026-10-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 RACC 8.2%≈ $8.0m new 13G 2026-05-28
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.1%≈ $37.8m +0.8 pts 13G 2026-08-14
SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 STRO 7.9%≈ $43.3m +2.5 pts 13G 2026-08-14
PALISADE BIO INC PALI · 13G · filed 2026-05-15 PALI 7.9%≈ $29.5m -2.1 pts 13G 2026-05-15
IMMATICS N.V IMTX · 13D · filed 2026-08-27 IMTX 7.6%≈ $113.5m 13D 2026-08-27
AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 AMLX 7.5%≈ $148.8m -0.7 pts 13G 2026-05-15
SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 SABS 7.3%≈ $25.8m -1.1 pts 13G 2026-08-14

Trades reported as a company insider in Q2 2024

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2024-04-11 ACRIVON THERAPEUTICS INC 10% owner · See Footnote ACRV Bought 2,353,000 $20.0m2.4m shares +78%
2024-04-05 ALDEYRA THERAPEUTICS INC 10% owner · See Footnote ALDX Bought 37,712 $178.8k37.7k shares +<1%
2024-04-04 ALDEYRA THERAPEUTICS INC 10% owner · See Footnote ALDX Bought 140,281 $655.1k140.3k shares +2%
2024-04-03 ALDEYRA THERAPEUTICS INC 10% owner · See Footnote ALDX Bought 309,847 $1.3m309.8k shares +4%
2024-04-02 ALDEYRA THERAPEUTICS INC 10% owner · See Footnote ALDX Bought 186,051 $640.0k186.1k shares +2%
2024-04-01 ALDEYRA THERAPEUTICS INC 10% owner · See Footnote ALDX Bought 8,374 $27.2k8.4k shares +<1%